Globus Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2009
Net Income	122.87	190.17	149.19	102.29	155.21	Upgrade
Depreciation & Amortization	144.73	68.25	69.87	62.87	52.73	Upgrade
Share-Based Compensation	52.74	32.81	30.59	27.07	26.09	Upgrade
Other Operating Activities	-76.85	-112.76	26.63	6.56	-62.05	Upgrade
Operating Cash Flow	243.5	178.47	276.27	198.79	171.98	Upgrade
Operating Cash Flow Growth	36.44%	-35.40%	38.98%	15.59%	-5.32%	Upgrade
Capital Expenditures	-78.27	-74.05	-56.9	-63.66	-70.75	Upgrade
Acquisitions	-296.03	-31.44	-34.49	-33.48	-23.8	Upgrade
Change in Investments	677.27	-4.88	-284.55	-20.18	-45.73	Upgrade
Investing Cash Flow	302.97	-110.36	-375.94	-117.32	-140.28	Upgrade
Share Issuance / Repurchase	-213.17	-102.78	63.5	-32.35	31.04	Upgrade
Other Financing Activities	-18.66	-7.19	-9.35	-6.32	-6.6	Upgrade
Financing Cash Flow	-231.82	-109.96	54.15	-38.66	24.44	Upgrade
Exchange Rate Effect	2.18	-0.75	-0.81	0.87	-0.16	Upgrade
Net Cash Flow	316.83	-42.6	-46.33	43.67	55.98	Upgrade
Free Cash Flow	165.23	104.42	219.38	135.14	101.23	Upgrade
Free Cash Flow Growth	58.23%	-52.40%	62.34%	33.50%	-20.26%	Upgrade
Free Cash Flow Margin	10.53%	10.21%	22.90%	17.13%	12.89%	Upgrade
Free Cash Flow Per Share	1.46	1.04	2.18	1.37	1.02	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).